Global tax technology company Vertex Inc. has appointed Ralf Gärtner as senior vice president and regional manager for Europe ...

SCB 10X, the disruptive technology investment arm of SCBX Group, announced its participation in the $50 million Series B ...

An upcoming webinar will demonstrate how the recently launched Veo3.1 can help generate cinematic video at scale and even ...

Fintel reports that on November 4, 2025, Stifel maintained coverage of Vertex (NasdaqGM:VERX) with a Hold recommendation.

Fintel reports that on November 4, 2025, Citizens maintained coverage of Vertex (NasdaqGM:VERX) with a Market Outperform ...

The stock's fall snapped a three-day winning streak.

Vertex Pharmaceuticals (VRTX) is rated as a "Strong Buy" due to robust revenue growth and multiple expansion opportunities ...

A new consensus report on the management of type 1 diabetes in adults was presented recently at the European Association for ...

While the launches of Journavx and Casgevy have started to build steam, “investors may not be inclined to look past the clear revenue misses,” wrote a Raymond James analyst.

Partnership aims to improve health outcomes and to transform the health and life insurance sector ...

US biopharma Vertex Pharmaceuticals has reported consolidated financial results for the third quarter of 2025 and refined its ...

Baystreet.ca News Commentary – The global biologics industry is experiencing unprecedented expansion as the market surges ...